Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11260012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Activated protein C (APC) resistance is the most frequently diagnosed heritable thrombophilic defect predisposing to thrombosis. To determine the prevalence of APC resistance due to factor V Leiden mutation in patients with leg ulcers. Within a 2-year-period 100 consecutive patients with leg ulcers were examined for factor V Leiden mutation. APC resistance due to factor V Leiden mutation was detected in 19 of 53 patients (36%) with post-thrombotic leg ulcers and in three of 47 patients (6%) with ulcers caused by primary varicosis. In a healthy control group APC resistance due to factor V Leiden mutation was found in five of 96 (5%) volunteers. In view of this high prevalence of APC resistance of 36%, which has never previously been reported, patients with post-thrombotic leg ulcers should be investigated for APC resistance.
Medical subject headings
- Activated Protein C Resistance
- Factor V
- Point Mutation
- Postphlebitic Syndrome
- Varicose Ulcer